The health effects of at-home written emotional disclosure in fibromyalgia: A randomized trial

Annals of Behavioral Medicine

Volumn 32, Issue 2, 2006, Pages 135-146

  Gillis, Mazy E ^a   Lumley, Mark A ^a,c   Mosley Williams, Angelia ^a   Leisen, James C C ^b   Roehrs, Timothy ^b  

^a WAYNE STATE UNIVERSITY   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMOTIONAL STRESS; FEMALE; FIBROMYALGIA; FOLLOW UP; GLOBAL CHANGE; HEALTH CARE UTILIZATION; HOME MENTAL HEALTH CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; OUTCOME ASSESSMENT; PHYSICAL DISABILITY; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER;

ADULT; AFFECT; AGED; ARTHRITIS, RHEUMATOID; EXPRESSED EMOTION; FATIGUE; FEMALE; FIBROMYALGIA; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; LINGUISTICS; MALE; MIDDLE AGED; SELF DISCLOSURE; SOCIAL SUPPORT; VERBAL BEHAVIOR;

EID: 33749588151     PISSN: 08836612     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15324796abm3202_11     Document Type: Conference Paper

References (77)

1. Hayes SC, Wilson KG, Gifford EV, Follette VM, Strosahl K: Experimental avoidance and behavioral disorders: A functional dimensional approach to diagnosis and treatment. Journal of Consulting & Clinical Psychology. 1996, 64:1152-1168.
2. Barlow DH, Allen LB, Choate ML: Toward a unified treatment for emotional disorders. Behavior Therapy. 2004, 35:205-230.
3. Taylor GJ, Bagby RM, Parker JDA: Disorders of Affect Regulation: Alexithymia in Medical and Psychiatric Illness. Cambridge, UK: Cambridge University Press, 1997.
4. Austenfeld JL, Stanton AL: Coping through emotional approach: A new look at emotion, coping, and health-related outcomes. Journal of Personality. 2004, 72:1335-1363.
5. Wenzlaff RM, Wegner DM: Thought suppression. Annual Review of Psychology. 2000, 51:59-91.
6. John OP, Gross JJ: Healthy and unhealthy emotion regulation: Personality processes, individual differences, and life span development. Journal of Personality. 2004, 72:1301-1333.
7. Lepore SJ, Greenberg MA: Mending broken hearts: Effects of expressive writing on mood, cognitive processing, social adjustment and health following a relationship breakup. Psychology & Health. 2002, 17:547-560.
8. Ullrich PM, Lutgendorf SK: Journaling about stressful events: Effects of cognitive processing and emotional expression. Annals of Behavioral Medicine. 2002, 24:244-250.
9. Greenberg MA, Stone AA: Emotional disclosure about traumas and its relation to health: Effects of previous disclosure and trauma severity. Journal of Personality & Social Psychology. 1992, 63:75-84.
10. Greenberg MA, Wortman CB, Stone AA: Emotional expression and physical heath: Revising traumatic memories or fostering self-regulation? Journal of Personality & Social Psychology. 1996, 71:588-602.
11. King LA, Miner KN: Writing about the perceived benefits of traumatic events: Implications for physical health. Personality & Social Psychology Bulletin. 2000, 26:220-230.
12. Esterling BA, Antoni MH, Fletcher MA, Margulies S, Schneiderman N: Emotional disclosure through writing or speaking modulates latent Epstein-Barr virus antibody titers. Journal of Consulting & Clinical Psychology. 1994, 62:130-140.
13. Petrie KJ, Booth RJ, Pennebaker JW, Davison KP, Thomas MG: Disclosure of trauma and immune response to a hepatitis B vaccination program. Journal of Consulting & Clinical Psychology. 1995, 63:787-792.
14. Cameron LD, Nicholls G: Expression of stressful experiences through writing: Effects of a self-regulation manipulation for pessimists and optimists. Health Psychology. 1998, 17:84-92.
15. Pennebaker JW, Colder M, Sharp LK: Accelerating the coping process. Journal of Personality & Social Psychology. 1990, 58:528-537.
16. Klein K, Boals A: Expressive writing can increase working memory capacity. Journal of Experimental Psychology: General. 2001, 130:520-533.
17. Smyth JM: Written emotional expression: Effect sizes, outcome types, and moderating variables. Journal of Consulting & Clinical Psychology. 1998, 66:174-184.
18. Smyth JM, Stone AA, Hurewitz A, Kaell A: Effects of writing about stressful experiences on symptom reduction in patients with asthma or rheumatoid arthritis: A randomized trial. Journal of the American Medical Association. 1999, 281: 1304-1309.
19. Warner LJ, Lumley MA, Casey RJ, et al.: Health effects of written emotional disclosure in adolescents with asthma: A randomized, controlled trial. Journal of Pediatric Psychology. 2006, 31:557-568.
20. Stanton AL, Danoff-Burg S, Sworowski LA, et al.: Randomized, controlled trial of written emotional expression and benefit finding in breast cancer patients. Journal of Clinical Oncology. 2002, 20:4160-4168.
21. Petrie KJ, Fontanilla I, Thomas MG, Booth RJ, Pennebaker JW: Effect of written emotional expression on immune function in patients with human immunodeficiency virus infection: A randomized trial. Psychosomatic Medicine. 2004, 66:272-275.
22. Solano L, Donati V, Pecci F, Persichetti S, Colaci A: Postoperative course after papilloma resection: Effects of written disclosure of the experience in subjects with different alexithymia levels. Psychosomatic Medicine. 2003, 65:477-484.
23. Gidron Y, Duncan E, Lazar A, et al.: Effects of guided written disclosure of stressful experiences on clinic visits and symptoms in frequent clinic attenders. Family Practice. 2002, 19:161-166.
24. de Moor C, Sterner J, Hall M, et al.: A pilot study of the effects of expressive writing on psychological and behavioral adjustment in patients enrolled in a Phase II trial of vaccine therapy for metastatic renal cell carcinoma. Health Psychology. 2002, 21:615-619.
25. Rosenberg HJ, Rosenberg SD, Ernstoff MS, et al.: Expressive disclosure and health outcomes in a prostate cancer population. International Journal of Psychiatry in Medicine. 2002, 32:37-53.
26. Norman SA, Lumley MA, Dooley JA, Diamond MP: For whom does it work? Moderators of the effects of written emotional disclosure in a randomized trial among women with chronic pelvic pain. Psychosomatic Medicine. 2004, 66:174-183.
27. Kelley JE, Lumley MA, Leisen JCC: Health effects of emotional disclosure in rheumatoid arthritis patients. Health Psychology. 1997, 16:331-340.
28. Broderick JE, Stone AA, Smyth JM, Kaell AT: The feasibility and effectiveness of an expressive writing intervention for rheumatoid arthritis via home-based videotaped instructions. Annals of Behavioral Medicine. 2004, 27:50-59.
29. Walker BL, Nail LM, Croyle RT: Does emotional expression make a difference in reactions to breast cancer? Oncology Nursing Forum. 1999, 26:1025-1032.
30. Harris AHS, Thoresen CE, Humphreys K, Faul J: Does writing affect asthma? A randomized trial. Psychosomatic Medicine. 2005, 67:130-136.
31. Rivkin ID, Gustafson J, Weingarten I, Chin D: The effects of expressive writing on adjustment to HIV. AIDS and Behavior. 2006, 10:13-26.
32. Bower JE, Kemeny ME, Taylor SE, Fahey JL: Finding positive meaning and its association with natural killer cell cytotoxicity among participants in a bereavement-related disclosure intervention. Annals of Behavioral Medicine. 2003, 25:146-155.
33. Stroebe M, Stroebe W, Schut H, Zech E, van den Bout J: Does disclosure of emotions facilitate recovery from bereavement? Evidence from two prospective studies. Journal of Consulting & Clinical Psychology. 2002, 70:169-178.
34. Klapow JC, Schmidt SM, Taylor LA, et al.: Symptom management in older primary care patients: feasibility of an experimental, written self-disclosure protocol. Annals of Internal Medicine. 2001, 134:905-911.
35. Schilte AF, Portegijs PJ, Blankenstein AH, et al.: Randomised controlled trial of disclosure of emotionally important events in somatisation in primary care. British Medical Journal. 2001, 325:1-6.
36. Ames SC, Patten CA, Offord KP, et al.: Expressive writing intervention for young adult cigarette smokers. Journal of Clinical Psychology. 2005, 61:555-1570.
37. Frisina PG, Borod JC, Lepore SJ: A meta-analysis of the effects of written emotional disclosure on the health outcomes of clinical populations. Journal of Nervous & Mental Disease. 2004, 192:629-634.
38. Gidron Y, Peri T, Connolly JF, Shalev AY: Written disclosure in posttraumatic stress disorder: Is it beneficial for the patient? Journal of Nervous and Mental Disease. 1996, 184:505-507.
39. Richards JM, Beal WE, Seagal JD, Pennebaker JW: Effects of disclosure of traumatic events on illness behavior among psychiatric prison inmates. Journal of Abnormal Psychology: 2000, 109:156-160.
40. Sloan DM, Marx BP: A closer examination of the structured written disclosure procedure. Journal of Consulting & Clinical Psychology. 2004, 72:165-175.
41. Lepore SJ, Greenberg MA, Bruno M, Smyth JM: Expressive writing and health: Self-regulation of emotion-related experience, physiology, and behavior. In Lepore SJ, Smyth JM (eds) The writing cure: How expressive writing promotes health and emotional well-being. Washington, DC: American Psychological Association, 2002, 99-117.
42. Pennebaker JW, Keough KA: Revealing, organizing, and reorganizing the self in response to stress and emotion. In Contrada RJ, Ashmore RD (eds), Self, social identity, and physical health: Interdisciplinary explorations. New York: Oxford University Press, 1999, 101-121.
43. Sloan DM, Marx BP: Taking pen to hand: Evaluating theories underlying the written disclosure paradigm. Clinical Psychology: Science & Practice. 2004, 11:121-137.
44. Foa EB, Zoellner LA, Feeny NC, Hembree EA, Alvarez-Conrad J: Does imaginal exposure exacerbate PTSD symptoms? Journal of Consulting and Clinical Psychology. 2002, 70:1022-1028.
45. Tarrier N, Pilgrim H, Sommerfield C, et al.: A randomized trial of cognitive therapy and imaginal exposure in the treatment of chronic posttraumatic stress disorder. Journal of Consulting and Clinical Psychology. 1999, 67:13-18.
46. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L: The prevalence and characteristics of fibromyalgia in the general population. Arthritis & Rheumatism. 1995, 38:19-28.
47. Wolfe F, Ross K, Anderson J, Russell IJ: Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms. Journal of Rheumatology. 1995, 22:151-156.
48. Goldenberg DL, Simms RW, Geiger A, Komaroff AL: High frequency of fibromyalgia in patients with chronic fatigue seen in a primary care practice. Arthritis & Rheumatism. 1990, 33:381-387.
49. Walker EA, Keegan D, Gardner G, et al.: Psychosocial factors in fibromyalgia compared with rheumatoid arthritis: II. Sexual, physical, and emotional abuse and neglect. Psychosomatic Medicine. 1997, 59:572-577.
50. Van Houdenhove B, Neerinckx E, Lysens R, et al.: Victimization in chronic fatigue syndrome and fibromyalgia in tertiary care: a controlled study on prevalence and characteristics. Psychosomatics. 2001, 42:21-28.
51. Anderberg UM, Marteinsdottir I, Theorell T, von Knorring L: The impact of life events in female patients with fibromyalgia and in female healthy controls. European Psychiatry. 2000, 15:295-301.
52. McBeth J, Macfarlane GJ, Benjamin S, Morris S, Silman AJ: The association between tender points, psychological distress, and adverse childhood experiences: A community-based study. Arthritis & Rheumatism. 1999, 42:1397-1404.
53. Yunus MB: Psychological aspects of fibromyalgia syndrome: A component of the dysfunctional spectrum syndrome. Baillieres Clinical Rheumatology. 1994, 8:811-837.
54. Sherman JJ, Turk DC, Okifuji A: Prevalence and impact of posttraumatic stress disorder-like symptoms on patients with fibromyalgia syndrome. Clinical Journal of Pain. 2000, 16:127-134.
55. Cohen H, Neumann L, Haiman Y, et al.: Prevalence of post-traumatic stress disorder in fibromyalgia patients: overlapping syndromes or post-traumatic fibromyalgia syndrome? Seminars in Arthritis & Rheumatism. 2002, 32:38-50.
56. Bansevicius D, Westgaard RH, Stiles T: EMG activity and pain development in fibromyalgia patients exposed to mental stress of long duration. Scandinavian Journal of Rheumatology. 2001, 30:92-98.
57. Davis MC, Zautra AJ, Reich JW: Vulnerability to stress among women in chronic pain from fibromyalgia and osteoarthritis. Annals of Behavioral Medicine. 2001, 23:215-226.
58. Brosschot JF, Aarsse HR: Restricted emotional processing and somatic attribution in fibromyalgia. International Journal of Psychiatry in Medicine. 2001, 57:127-146.
59. Dailey PA, Bishop GD, Russell IJ, Fletcher EM: Psychological stress and the fibrositis/fibromyalgia syndrome. Journal of Rheumatology. 1990, 17:1380-1385.
60. Sayar K, Gulec H, Topbas M: Alexithymia and anger in patients with fibromyalgia. Clinical Rheumatology. 2004, 23:441-448.
61. Lumley MA, Smith JA, Longo DJ: The relationship of alexithymia to pain severity and impairment among patients with chronic myofascial pain: Comparisons with self-efficacy, catastrophizing, and depression. Journal of Psychosomatic Research. 2002, 53:823-830.
62. Smith JA, Lumley MA, Longo DJ: Contrasting emotional approach coping with passive coping for chronic myofascial pain. Annals of Behavioral Medicine. 2002, 24:326-335.
63. Broderick JE, Junghaenel DU, Schwartz JE: Written emotional expression produces health benefits in fibromyalgia patients. Psychosomatic Medicine. 2005, 67:326-334.
64. Park CL, Blumberg CJ: Disclosing trauma through writing: Testing the meaning-making hypothesis. Cognitive Therapy & Research. 2002, 26:597-616.
65. Wolfe F, Smythe HA, Yunus MB, et al.: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis & Rheumatism. 1990, 33:160-172.
66. Pennebaker JW, Francis ME, Booth RJ: Linguistic Inquiry and Word Count (LIWC): LIWC2001. Mahwah, NJ: Lawrence Erlbaum Associates, Inc., 2001.
67. Labouvie-Vief G, Lumley MA, Jain E, Heinze H: Age and gender differences in cardiac reactivity and subjective emotion responses to emotional autobiographical memories. Emotion. 2003, 3:115-126.
68. Watson D, Clark LA: The PANAS-X. Manual for the Positive and Negative Affect Schedule-Expanded Form. Iowa City: University of Iowa Press, 1994.
69. Burckhardt CS, Clark SR, Bennett RM: The fibromyalgia impact questionnaire: Development and validation. Journal of Rheumatology. 1991, 18:728-733.
70. White KP, Harth M: An analytical review of 24 controlled clinical trials for fibromyalgia syndrome (FMS). Pain. 1996, 64:211-219.
71. Dunkl PR, Taylor AG, McConnell GG, Alfano AP, Conaway MR: Responsiveness of fibromyalgia clinical trial outcome measures. Journal of Rheumatology. 2000, 27:2683-2691.
72. Meenan RF, Mason JH, Anderson JJ, Guccione AA, Kazis LE: AIMS2. The content and properties of a revised and expanded Arthritis Impact Measurement Scales Health Status Questionnaire. Arthritis & Rheumatism. 1992, 35:1-10.
73. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD: The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Archives of Neurology. 1989, 46:1121-1123.
74. Roehrs T, Bonahoom A, Pedrosi B, Rosenthal L, Roth T: Treatment regimen and hypnotic self-administration. Psychopharmacology. 2001, 155:11-17.
75. Sloan DM, Marx BP, Epstein EM: Further examination of the exposure model underlying the efficacy of written emotional disclosure. Journal of Consulting and Clinical Psychology. 2005, 73:549-554.
76. Neale JM, Cox DS, Valdimarsdottir H, Stone AA: The relation between immunity and health: Comment on Pennebaker, Kiecolt-Glaser, and Glaser. Journal of Consulting & Clinical Psychology. 1988, 56:636-637.
77. Leserman J: Sexual abuse history: Prevalence, health effects, mediators, and psychological treatment. Psychosomatic Medicine. 2005, 67:906-915.